PharmD, President, Precision Oncology (Part of Precision for Medicine)
Patricia Devitt Risse, Pharm.D is the President of Precision Oncology (part of Precision for Medicine), the first precision medicine research organization focused in oncology – combining clinical trial expertise with advanced biomarker solutions. She provides executive leadership to the company and strategic protocol design and study optimization guidance to sponsors. Dr. Devitt Risse has more than three decades of broad-based oncology experience in both global and domestic clinical research environments, including large pharmaceutical companies, biotech companies and CROs. Dr. Devitt Risse earned her Doctor of Pharmacy from Rutgers University and was named by NJBIZ as one of the Best 50 Women in Business in 2014, as a PACT Enterprise Healthcare CEO finalist in 2015, as a EY Finalist for Entrepreneur Of The Year© award for the state of New Jersey in 2015 and as an award winner of the PACT Enterprise Award for Emerging Healthcare company in 2016.
Presentation Title and Company Description
Immunotherapy Showcase: Mastering Operational Challenges in Precision Oncology Protocols
Precision Oncology is an oncology development company, combining market leading oncology clinical trial design and execution with the most advanced biomarker expertise and infrastructure. The result is a uniquely integrated offering built to deliver an accelerated pathway to approval for oncology innovators.